Atovaquone Suspension
Product Images NDC 50268-119

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 50268-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (119 12)

This is information about Atovaquone Oral Suspension, USP. Each 5 mL contains 50 mg of Atovaquone. It is indicated for prescription use only and should be stored at 15° to 25°C. The suspension should be gently shaken before use. Additionally, it states that each 5 mL contains 750 mg of Atovaquone and no more than 0.27% alcohol. The usual dosage instructions are provided in the package insert.*

FDA Label Image

Structure (Atovaquone Oral Suspension 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.